F. Nardelli

发表

Benzofused hydroxamic acids: useful fragments for the preparation of histone deacetylase inhibitors. Part 1: hit identification.

M. Binaschi, C. Maggi, D. Fattori, 2013, Bioorganic & medicinal chemistry letters.

Substance P activates responses correlated with tumour growth in human glioma cell lines bearing tachykinin NK1 receptors

C. Maggi, F. Nardelli, C. Palma, 1999, British Journal of Cancer.

Correlation between binding characteristics and functional antagonism in human glioma cells by tachykinin NK1 receptor antagonists.

F. Nardelli, C. Palma, S. Manzini, 1999, European journal of pharmacology.

Induction of a less aggressive phenotype in human colon carcinoma HCT116 cells by chronic exposure to HDAC inhibitor SAHA.

M. Binaschi, C. Maggi, M. Bigioni, 2010, Oncology reports.

Apoptotic events in a human ovarian cancer cell line exposed to anthracyclines.

C. Maggi, C. Goso, A. Bullo, 2001, The Journal of pharmacology and experimental therapeutics.

Constitutive expression of E- and P-selectin cognate ligands in human endothelial cells.

F. Nardelli, C. Palma, S. Manzini, 1998, Mediators of inflammation.

4-N-Hydroxy-4-[1-(sulfonyl)piperidin-4-yl]-butyramides as HDAC inhibitors.

M. Binaschi, C. Maggi, D. Fattori, 2011, Bioorganic & medicinal chemistry letters.

Alkyl piperidine and piperazine hydroxamic acids as HDAC inhibitors.

M. Binaschi, C. Maggi, D. Fattori, 2011, Bioorganic & medicinal chemistry letters.

Synthesis and biological evaluation of rebeccamycin analogues modified at the imide moiety.

M. Binaschi, M. Berettoni, A. Cipollone, 2012, Bioorganic & medicinal chemistry letters.

Anti-tumour activity of tachykinin NK1receptor antagonists on human glioma U373 MG xenograft

C. Maggi, M. Bigioni, F. Nardelli, 2000, British Journal of Cancer.

Sabarubicin (MEN10755)-induced apoptosis is independent from mtDNA in A2780 human ovarian tumor cells.

M. Binaschi, C. Maggi, M. Bigioni, 2007, Anticancer research.